Circassia Pharmaceuticals is exercising an option to acquire the full US commercial rights to AstraZeneca’s Tudorza. More: Circassia takes on full US rights to AZ’ Tudorza Source: News
read moreThe National Institute for Health and Care Excellence has published new standards setting out the requirements needed to develop digital health technologies for the NHS, to accelerate uptake of products like healthcare apps and wearable devices. More: New NICE standards
read moreThe largest ever lung cancer screening project undertaken in the UK has launched in London, aiming to detect lung cancer early among at-risk citizens. More: Launch of largest ever UK lung cancer screening study Source: News
read moreOxford BioTherapeutics has entered a strategic partnership with WuXi Biologics to develop bispecific antibodies for the treatment of several cancer types, expanding on the existing collaboration between the two. More: Oxford BioTherapeutics, WuXi Biologics team up to create cancer antibodies
read morePredictImmune is gearing up to launch its novel prognostic test for inflammatory disease after it was awarded a CE mark. More: PredictSURE IBD gains CE mark, set for UK and EU launch Source: News
read moreMerck & Co. boasted some major success in the sales department this year, but the company’s commercial organization will still get a makeover for 2019. Adam Schechter, president of global human health, will leave on Dec. 31, triggering an executive
read more© 1994 - 2026 B.M. Pharmaceuticals